SCHEMBL8224985

SCHEMBL8224985

CC(=O)N(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2C(C)=O

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.59
TDP1 Q9NUW8 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
NOX1 Q9Y5S8 1/20 0.47
SNCA P37840 4/20 0.45
BCHE P06276 5/20 0.42
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.35
P2RX4 Q99571 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.33
PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1208061 0.93 MAPK1 (0.67) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL29557693 0.93 MAPK1 (0.67) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL10353761 0.86 MAPK1 (0.51) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL21752063 0.86 SNCA (0.60) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL1926806 0.86 NOX1 (0.69) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL20737960 0.83 MAPK1 (0.56) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL11595006 0.83 MAPK1 (0.56) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL10353757 0.82 MEN1 (0.42) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL21752026 0.82 SNCA (0.69) MAPK1TDP1MEN1KMT2AL3MBTL1
SCHEMBL18408661 0.82 MAPK1 (0.55) MAPK1TDP1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0170188-B1 NOVEL PHENOTHIAZINES, PREPARATION THEREOF AND USE THEREOF IN ELECTROCHROMIC RECORDING SYSTEMS THE HILTON - DAVIS CHEMICAL COMPANY (US) 1990-08-29 EP claimed
US-4652643-A LEUCO DYES THE HILTON-DAVIS CHEMICAL COMPANY (US) 1987-03-24 US claimed
EP-0170188-A1 Novel phenothiazines, preparation thereof and use thereof in electrochromic recording systems THE HILTON - DAVIS CHEMICAL COMPANY (US) 1986-02-05 EP claimed
US-4561001-A SUPPORT SHEET CONTAING PHENOTHIAZINE COLOR FORMER THE HILTON-DAVIS CHEMICAL CO. (US) 1985-12-24 US claimed
EP-3121169-B1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LAB LTD (SG) 2022-02-09 EP disclosed
US-20210322435-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS Wis Ta Laboratories Ltd. (SG) 2021-10-21 US disclosed
US-11045477-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2021-06-29 US disclosed
US-20200261465-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2020-08-20 US disclosed
US-9980971-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2018-05-29 US disclosed
US-9980971-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2018-05-29 US disclosed
US-20170273986-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2017-09-28 US disclosed
US-20170273986-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2017-09-28 US disclosed
EP-2457905-A1 Methods of synthesis and/or purification of diaminophenothiazinium compounds Wista Laboratories Ltd. (SG) 2012-05-30 EP disclosed
US-20110294795-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. 2011-12-01 US disclosed
US-20110294795-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. 2011-12-01 US disclosed
US-7956183-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2011-06-07 US disclosed
US-7956183-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2011-06-07 US disclosed
US-20090259040-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2009-10-15 US disclosed
US-20090259040-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2009-10-15 US disclosed
WO-2008007074-A2 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273986-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MB, TPMT, HBB MAPK1 3258/4885TDP1 1840/4885MEN1 330/4885
US-20210322435-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MB, TPMT, HBB MAPK1 3258/4885TDP1 1840/4885MEN1 330/4885
US-11045477-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds MB, TPMT, HBB MAPK1 3258/4885TDP1 1840/4885MEN1 330/4885
US-20090259040-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS PARK7, SNCA, GRN MAPK1 3312/4885TDP1 583/4885MEN1 674/4885
US-20110294795-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MMAB, MB, ABCB7 MAPK1 2386/4885TDP1 3023/4885MEN1 20/4885
US-20200261465-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MB, TPMT, HBB MAPK1 3258/4885TDP1 1840/4885MEN1 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.